Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
495 studies found for:    Open Studies | "Pancreatic Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Gemcitabine and CT-011 for Resected Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of the Pancreas;   Neoplasms Pancreatic;   Pancreatic Cancer;   Pancreas Cancer
Interventions: Biological: CT-011;   Drug: Gemcitabine
2 Recruiting Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Conditions: Pancreas Cancer;   Localized Pancreas Cancer;   Non-metastatic Pancreas Cancer
Intervention: Drug: FOLFIRINOX Regimen
3 Recruiting Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Interventions: Drug: Gemcitabine and cisplatin;   Drug: Gemcitabine / Cisplatin
4 Recruiting Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer
Conditions: Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreas Neoplasms
Interventions: Drug: Modified FOLFIRINOX;   Radiation: Stereotactic Body Radiotherapy (SBRT)
5 Recruiting PANFIRE - Pilot-study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma
Conditions: Locally Advanced Pancreatic Carcinoma (LAPC);   Non-metastasized Unresectable Pancreatic Carcinoma;   Pancreatic Cancer
Intervention: Device: NanoKnife "Irreversible electroporation (IRE)"
6 Recruiting Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas
Conditions: Pancreatic Cyst;   Pancreatic Neoplasms;   Pancreatic Adenoma;   Pancreatic Cancer;   Pancreatic Islet Cell Tumors;   Lymph Node;   Lymphadenopathy
Interventions: Procedure: EUS-FNA;   Device: nCLE
7 Recruiting Registry Trial for Clinical Evaluation of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Conditions: Pancreatic Cyst;   Pancreatic Neoplasms;   Pancreatic Adenoma;   Pancreatic Cancer;   Pancreatic Islet Cell Tumors;   Lymph Node;   Lymphadenopathy;   GIST
Intervention: Device: EUS-FNA: Endoscopic ultrasound fine needle aspiration: ultrasound endoscopy of a lesion with aspiration of the lesion fluid through a needle
8 Recruiting Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Dietary Supplement: Ketogenic diet
9 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome;   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin
10 Recruiting Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreatic Carcinoma Non-resectable;   Locally Advanced Malignant Neoplasm
Interventions: Drug: FOLFIRINOX;   Biological: Algenpantucel-L Immunotherapy;   Radiation: 5-FU Chemoradiation;   Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Nab-Paclitaxel
11 Not yet recruiting Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
Condition: Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Gemcitabine;   Drug: Chemoradiation;   Drug: Capecitabine;   Procedure: Surgery
12 Unknown  Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Condition: Pancreatic Neoplasms
Interventions: Device: Heckel Infrared Radiant Heat Device;   Other: cisplatin, gemcitabine, interferon-alpha;   Other: thermochemotherapy
13 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
14 Recruiting Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed by Surgery
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Dasatinib;   Drug: Erlotinib Hydrochloride
15 Recruiting Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
Condition: Pancreas Cancer
Interventions: Drug: gemcitabine;   Drug: 5-fluorouracil
16 Recruiting Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
Condition: Pancreatic Tumor
Intervention: Procedure: suspected pancreatic tumor
17 Recruiting DCE MRI in Diagnosing Patients With Pancreatic Cancer
Conditions: Hereditary Pancreatic Cancer;   Intraductal Papillary Mucinous Neoplasm of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Procedure: dynamic contrast-enhanced magnetic resonance imaging
18 Not yet recruiting Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia
Conditions: Pancreatic Neoplasms;   Cholestasis
Interventions: Drug: nab-paclitaxel;   Drug: Gemcitabine
19 Recruiting Tumor Registry Pancreatic Cancer
Condition: Pancreas Cancer
Intervention:
20 Not yet recruiting Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Radiation: neoadjuvant short course IMRT;   Radiation: IORT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years